|   | x | QUARTERLY      REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|--------|---|---------------------------------------------------------------------------------------------|

|   | o         | TRANSITION      REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE  ACT |
|--------|---------------------|-----------------------------------------------------------------------|

| Delaware                                                                                        | 37-1532843                             |
|-------------------------------------------------------------------------------------------------|----------------------------------------|
| (State      or other jurisdiction of incorporation or      organization)    | (IRS      Employer Identification No.) |
|                                                                                            |                                   |

| Large      accelerated filer o                                                                      | Accelerated      filer  o         |
|---------------------------------------------------------------------------------------------------------------|----------------------------------------|
| Non-accelerated      filer   o  (Do not      check if a smaller reporting company)   | Smaller      reporting company  x |

----

| PART      I.           | FINANCIAL      INFORMATION                                                                                                                                                         | Page       Number |
|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|
|                   |                                                                                                                                                                               |                   |
| Item      1.           | Financial      Statements                                                                                                                                                          |                   |
|                   |                                                                                                                                                                               |                   |
|                   | Condensed      Consolidated Balance Sheets as of September 30, 2009 (Unaudited) and      December 31, 2008                                                                         | 3                      |
|                   |                                                                                                                                                                               |                   |
|                   | Condensed      Consolidated Statements of Operations and Comprehensive Loss for the      three and nine months ended September 30, 2009 (Unaudited) and 2008      (Unaudited) | 4                      |
|                   |                                                                                                                                                                               |                   |
|                   | Condensed      Consolidated Statement of Stockholders’ Deficit for the nine      months ended September 30, 2009 (Unaudited)                                       | 5                      |
|                   |                                                                                                                                                                               |                   |
|                   | Condensed      Consolidated Statements of Cash Flows for the nine months ended September      30, 2009 (Unaudited) and 2008 (Unaudited)                                            | 6                      |
|                   |                                                                                                                                                                               |                   |
|                   | Notes      to Condensed Consolidated Financial      Statements (Unaudited)                                                                                          | 7                      |
|                   |                                                                                                                                                                               |                   |
| Item      2.           | Management's      Discussion and Analysis of Financial Condition and Results of      Operations                                                                                    | 18                     |
|                   |                                                                                                                                                                               |                   |
| Item      3.           | Quantitative      and Qualitative Disclosures about Market Risk                                                                                                                    | 23                     |
|                   |                                                                                                                                                                               |                   |
| Item      4T.          | Controls      and Procedures                                                                                                                                                       | 23                     |
|                   |                                                                                                                                                                               |                   |
| PART      II.          | OTHER      INFORMATION                                                                                                                                                             |                   |
|                   |                                                                                                                                                                               |                   |
| Item      1.           | Legal      Proceedings                                                                                                                                                             | 24                     |
|                   |                                                                                                                                                                               |                   |
| Item1A.                | Risk      Factors                                                                                                                                                                  | 24                     |
|                   |                                                                                                                                                                               |                   |
| Item      2.           | Unregistered      Sales of Equity Securities and Use of Proceeds                                                                                                                   | 24                     |
|                   |                                                                                                                                                                               |                   |
| Item      3.           | Defaults      Upon Senior Securities                                                                                                                                               | 24                     |
|                   |                                                                                                                                                                               |                   |
| Item      4.           | Submission      of Matters to a Vote of Security Holders                                                                                                                           | 24                     |
|                   |                                                                                                                                                                               |                   |
| Item      5.           | Other      Information                                                                                                                                                             | 24                     |
|                   |                                                                                                                                                                               |                   |
| Item      6.           | Exhibits                                                                                                                                                                           | 24                     |
|                   |                                                                                                                                                                               |                   |
| SIGNATURES        |                                                                                                                                                                               | 25                     |

| · | Part I      – Item 2. Management’s Discussion and Analysis of Financial Condition      and Results of Operations |
|--------|----------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                   |
| · | Part I      – Item 4. Controls andProcedures                                                                           |

----

|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------------------------|------------|--------|-------------------------------------|--------|
|                                                                                                                                                                                                                      |   | September      30, 2009(Unaudited) |       |   | December      31, 2008(Note      2) |   |
|                                                                                                                                                                                                                      |   | Restated                           |       |   |                                |   |
| ASSETS                                                                                                                                                                                                                    |   |                               |       |   |                                |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |
| Current      assets:                                                                                                                                                                                                      |   |                               |       |   |                                |   |
| Cash      and cash equivalents                                                                                                                                                                                            |   | $                                  | 112,335    |   |                                | $      | 144,546 |   |
| Accounts      receivable, net                                                                                                                                                                                             |   |                               | 408,605    |   |                                |   | 552,517 |   |
| Prepaid      expenses and other current assets                                                                                                                                                                            |   |                               | 23,083     |   |                                |   | 42,593 |   |
| Total      current assets                                                                                                                                                                                                 |   |                               | 544,023    |   |                                |   | 739,656 |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Property      and equipment, net                                                                                                                                                                                          |   |                               | 23,603     |   |                                |   | 34,266 |   |
| Other      assets                                                                                                                                                                                                         |   |                               | 2,952      |   |                                |   | 2,953 |   |
| Total      assets                                                                                                                                                                                                         |   | $                                  | 570,578    |   |                                | $      | 776,875 |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| LIABILITIES      AND DEFICIT                                                                                                                                                                                              |   |                               |       |   |                                |   |   |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Current      liabilities:                                                                                                                                                                                                 |   |                               |       |   |                                |   |   |   |
| Accounts      payable                                                                                                                                                                                                     |   | $                                  | 578,803    |   |                                | $      | 336,906 |   |
| Accrued      expenses                                                                                                                                                                                                     |   |                               | 464,591    |   |                                |   | 188,555 |   |
| Revolving      credit facility                                                                                                                                                                                            |   |                               | 53,764     |   |                                |   | 216,590 |   |
| Deferred      revenue                                                                                                                                                                                                     |   |                               | 180,455    |   |                                |   | 154,011 |   |
| Current      portion of long-term debt                                                                                                                                                                                    |   |                               | 493,138    |   |                                |   | 60,792 |   |
| Current      portion of capital lease obligations                                                                                                                                                                         |   |                               | 13,493     |   |                                |   | 16,242 |   |
| Preferred      stock dividends payable - stated                                                                                                                                                                           |   |                               | 178,208    |   |                                |   | 68,250 |   |
| Preferred      stock dividends payable - accreted                                                                                                                                                                         |   |                               | -          |   |                                |   | 395,585 |   |
| Common      stock put options                                                                                                                                                                                             |   |                               | -          |   |                                |   | 269,000 |   |
| Management      fee payable                                                                                                                                                                                               |   |                               | 113,978    |   |                                |   | 50,000 |   |
| Other      current liabilities                                                                                                                                                                                            |   |                               | 20,566     |   |                                |   | 5,299 |   |
| Total      current liabilities                                                                                                                                                                                            |   |                               | 2,096,996  |   |                                |   | 1,761,230 |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Long-term      debt, less current portion                                                                                                                                                                                 |   |                               | 196,469    |   |                                |   | 514,606 |   |
| Capital      lease obligations, less current portion                                                                                                                                                                      |   |                               | 8,402      |   |                                |   | 16,409 |   |
| Total      liabilities                                                                                                                                                                                                    |   |                               | 2,301,867  |   |                                |   | 2,292,245 |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Commitments      and contingencies                                                                                                                                                                                        |   |                               |       |   |                                |   |   |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Deficit:                                                                                                                                                                                                                  |   |                               |       |   |                                |   |   |   |
| Preferred      stock, par value $0.001; 10,000,000 sharesauthorized;      no shares issued as of September 30, 2009 and December 31, 2008,      respectively                                                              |   |                               | -          |   |                                |   | - |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Common      stock, $0.001 par value; 40,000,000 authorized; issued 2,735,516 and      outstanding 2,310,516 shares atSeptember      30, 2009; issued 2,192,094 and outstanding 1,383,483 shares at December      31, 2008 |   |                               | 2,736      |   |                                |   | 2,192 |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Treasury      stock, at cost; 425,000 and 808,611 shares at September 30, 2009 and      December 31, 2008, respectively                                                                                                   |   |                               | (40        | )      |                                |   | (974,015 | ) |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
| Additional      paid-in capital                                                                                                                                                                                           |   |                               | (187,719   | )      |                                |   | 540,997 |   |
| Common      stock put options                                                                                                                                                                                             |   |                               | -          |   |                                |   | (269,000 | ) |
| Accumulated      deficit                                                                                                                                                                                                  |   |                               | (1,483,705 | )      |                                |   | (812,782 | ) |
| Accumulated      other comprehensive income (loss)                                                                                                                                                                        |   |                               | 8,480      |   |                                |   | (2,762 | ) |
| Total      stockholders' deficit of Midas Medici Group Holdings,      Inc.                                                                                                                                                |   |                               | (1,660,248 | )      |                                |   | (1,515,370 | ) |
| Non-controlling      interest                                                                                                                                                                                             |   |                               | (71,041    | )      |                                |   | - |   |
| Total      deficit                                                                                                                                                                                                        |   |                               | (1,731,289 | )      |                                |   | (1,515,370 | ) |
| Total      liabilities and deficit                                                                                                                                                                                        |   | $                                  | 570,578    |   |                                | $      | 776,875 |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |
|                                                                                                                                                                                                                      |   |                               |       |   |                                |   |   |   |

----

|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |
|-------------------------------------------------------------------------------|--------|--------------------------------------------|-----------|--------|--------------------------------------------|--------|-----------|-------------------------------------------|--------|--------|-------------------------------------------|--------|
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |
|                                                                          |   | Three      Months Ended September 30, 2009 |      |   | Three      Months Ended September 30, 2008 |   |      | Nine      Months Ended September 30, 2009 |   |   | Nine      Months Ended September 30, 2008 |   |
|                                                                          |   | Restated                                   |      |   |                                       |   |      | Restated                                  |   |   |                                      |   |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |
| Net      revenues                                                             |   | $                                          | 837,404   |   |                                       | $      | 1,055,595 |                                      |   | $      | 2,566,962                                 |   |   | $ | 2,826,650 |   |
| Cost      of services                                                         |   |                                       | 506,153   |   |                                       |   | 599,581   |                                      |   |   | 1,445,193                                 |   |   |   | 1,485,006 |   |
| Gross      margin                                                             |   |                                       | 331,251   |   |                                       |   | 456,014   |                                      |   |   | 1,121,769                                 |   |   |   | 1,341,644 |   |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Operating      expenses:                                                      |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Selling,      general and administrative                                      |   |                                       | 820,474   |   |                                       |   | 493,683   |                                      |   |   | 1,784,968                                 |   |   |   | 1,338,676 |   |
| Depreciation      and amortization                                            |   |                                       | 4,421     |   |                                       |   | 4,464     |                                      |   |   | 13,835                                    |   |   |   | 12,207 |   |
| Total      operating expenses                                                 |   |                                       | 824,895   |   |                                       |   | 498,147   |                                      |   |   | 1,798,803                                 |   |   |   | 1,350,883 |   |
| Operating      loss                                                           |   |                                       | (493,644  | )      |                                       |   | (42,133   | )                                         |   |   | (677,034                                  | )      |   |   | (9,239 | ) |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Other      income (expense):                                                  |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Interest      income                                                          |   |                                       | 1         |   |                                       |   | -         |                                      |   |   | 2                                         |   |   |   | - |   |
| Interest      expense                                                         |   |                                       | (19,791   | )      |                                       |   | (19,888   | )                                         |   |   | (62,855                                   | )      |   |   | (49,332 | ) |
| Total      other income (expense)                                             |   |                                       | (19,790   | )      |                                       |   | (19,888   | )                                         |   |   | (62,853                                   | )      |   |   | (49,332 | ) |
| Loss      before income taxes                                                 |   |                                       | (513,434  | )      |                                       |   | (62,021   | )                                         |   |   | (739,887                                  | )      |   |   | (58,571 | ) |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Provision      (benefit) for income taxes                                     |   |                                       | -         |   |                                       |   | (13,879   | )                                         |   |   | 2,077                                     |   |   |   | (1,362 | ) |
| Net      loss                                                                 |   |                                       | (513,434  | )      |                                       |   | (48,142   | )                                         |   |   | (741,964                                  | )      |   |   | (57,209 | ) |
| Less:      Net loss attributable to the non-controllinginterest               |   |                                       | 69,634    |   |                                       |   | -         |                                      |   |   | 71,041                                    |   |   |   | - |   |
| Net      loss attributable to Midas Medici Group Holdings,    Inc.            |   |                                       | (443,800  | )      |                                       |   | (48,142   | )                                         |   |   | (670,923                                  | )      |   |   | (57,209 | ) |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Preferred      stock dividends and dividend accretion                         |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Preferred      stock stated dividends                                         |   |                                       | (41,708   | )      |                                       |   | (34,125   | )                                         |   |   | (109,958                                  | )      |   |   | (102,375 | ) |
| Preferred      stock dividend accretion                                       |   |                                       | (30,377   | )      |                                       |   | (72,285   | )                                         |   |   | (203,109                                  | )      |   |   | (201,659 | ) |
| Net      loss applicable to common stockholders                               |   | $                                          | (515,885  | )      |                                       | $      | (154,552  | )                                         |   | $      | (983,990                                  | )      |   | $ | (361,243 | ) |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Net      loss per common share (basic and diluted)                            |   | $                                          | (0.32     | )      |                                       | $      | (0.11     | )                                         |   | $      | (0.64                                     | )      |   | $ | (0.26 | ) |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Weighted      average common shares outstanding (basic and      diluted) |   |                                       | 1,600,037 |   |                                       |   | 1,355,631 |                                      |   |   | 1,531,736                                 |   |   |   | 1,372,730 |   |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Comprehensive      loss:                                                      |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
| Net      loss                                                                 |   | $                                          | (513,434  | )      |                                       | $      | (48,142   | )                                         |   | $      | (741,964                                  | )      |   | $ | (57,209 | ) |
| Foreign      currency translation                                             |   |                                       | (4,882    | )      |                                       |   | -         |                                      |   |   | 11,242                                    |   |   |   | - |   |
| Total      comprehensive loss                                                 |   |                                       | (518,316  | )      |                                       |   | (48,142   | )                                         |   |   | (730,722                                  | )      |   |   | (57,209 | ) |
| Comprehensive      loss attributable to the non-controlling interest          |   |                                       | 69,634    |   |                                       |   | -         |                                      |   |   | 71,041                                    |   |   |   | - |   |
| Comprehensive      loss attributable to Midas Medici Group Holdings,    Inc.  |   | $                                          | (448,682  | )      |                                       | $      | (48,142   | )                                         |   | $      | (659,681                                  | )      |   | $ | (57,209 | ) |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |
|                                                                          |   |                                       |      |   |                                       |   |      |                                      |   |   |                                      |   |   |   |   |   |

----

| Midas      Medici Group Holdings, Inc. and Subsidiaries         |
|-----------------------------------------------------------------|
| (Formerly      Utilipoint International, Inc. and Subsidiaries) |
| Condensed      Consolidated Statements of Stockholders' Deficit |
| Nine      Months Ended September 30, 2009                       |
| (Unaudited)                                                |
| Restated                                                        |
|                                                            |   |   |   |   |   |   |   |   |   |   |   |

|                                                                                                                                         |   | Common      Stock |      |    | Additional      Paid-in Capital |   |   | Treasury Stock |   |   | Common      Stock Put Options |    |   | Accumulated      Deficit |         |   | Accumulated      Other Comprehensive Income (Loss) |   |     | Total      Stockholders' Deficit |   |   | Non-Controlling      Interest |   |   | Total      Deficit |       |
|----------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------|-----------|---------|---------------------------------|--------|--------|---------------------|--------|--------|-------------------------------|---------|--------|--------------------------|--------------|--------|----------------------------------------------------|--------|----------|----------------------------------|--------|--------|-------------------------------|--------|--------|--------------------|------------|
|                                                                                                                                         |   | Shares            |      |    | Amount                          |   |   |                |   |   | Shares                        |    |   | Amount                   |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |
| Balance      - December 31, 2008                                                                                                             |   |              | 2,192,094 |    |                            | $      | 2,192  |                |   | $      | 540,997                       |    |   |                     | 808,611      |   |                                               | $      | (974,015 | )                                |   | $      | (269,000                      | )      |   | $                  | (812,782   | ) |   | $ | (2,762 | ) |   | $ | (1,515,370 | ) |   |   |   |   | $ | (1,515,370 | ) |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Sales      of common stock                                                                                                                   |   |              | 15,981    |    |                            |   | 16     |                |   |   | 24,984                        |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   | 25,000 |   |   |   |   |   |   | 25,000 |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Treasury      stock received at $0.00 cost                                                                                                   |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     | 50,948  |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   | - |   |   |   |   |   |   | - |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Effect      of reverse merger adjustments                                                                                                    |   |              | 1,387,000 |    |                            |   | 1,387  |                |   |   | (262,546                      | )       |   |                     | 425,000      |   |                                               |   | (40      | )                                |   |   |                          |   |   |               |       |   |   |   |   |   |   |   | (261,199 | ) |   |   |   |   |   | (261,199 | ) |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |
|  Accretion      of accelerated and balloon dividends on preferred    stock                                                              |   |              |      |    |                            |   |   |                |   |   | (203,109                      | )  |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   | (203,109 | )  |   |   |   |   |   | (203,109 | )  |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Elimination      of treasury stock upon reverse merger                                                                                       |   |              | (859,559  | )       |                            |   | (859   | )                   |   |   | (973,156                      | )       |   |                     | (859,559     | )      |                                               |   | 974,015  |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   | - |   |   |   |   |   |   | - |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Elimination      ofaccruedcommonstock      putoptionsupon      reversemerger                                                                 |   |              |      |    |                            |   |   | 269,000             |   |   |                          |    |   |                     |         |   |                                               |   |     | 269,000                          |   |   |                          |   |   |               | 269,000    |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Elimination      ofaccumulatedaccretion      ofacceleratedand      balloondividends      onpreferred      stock upon      reversemerger |   |              |      | 598,694 |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       | 598,694 |   |   |   |   |   |   | 598,694 |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Preferreddividends                                                                                                                           |   |              |      |    |                            |   |   | (109,958            | )      |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   | (109,958 | ) |   |   |   |   |   | (109,958 | ) |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Stock-basedcompensation                                                                                                                      |   |              |      |    |                            |   |   | 196,375             |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   | 196,375 |   |   |   |   |   |   | 196,375 |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Foreigncurrency      translation                                                                                                             |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       | 11,242 |   |   |   | 11,242 |   |   |   |   |   |   | 11,242 |   |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Loss      attributedto      Non-ControllingInterest                                                                                          |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       | - |   |   | $  | (71,041 | ) |   |   | (71,041 | ) |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|  Net      lossattributable      toMidas      MediciGroupHoldings,      Inc.                                                             |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               | (670,923   | )  |   |   |   |   |   |   | (670,923 | )  |   |   |   |   |   |   | (670,923 | )  |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance      - September 30, 2009                                                                                                            |   |              | 2,735,516 |    |                            | $      | 2,736  |                |   | $      | (187,719                      | )       |   |                     | 425,000      |   |                                               | $      | (40      | )                                |   | $      | -                             |   |   | $                  | (1,483,705 | ) |   | $ | 8,480 |   |   | $ | (1,660,248 | ) |   | $ | (71,041 | ) |   | $ | (1,731,289 | ) |
|                                                                                                                                         |   |              |      |    |                            |   |   |                |   |   |                          |    |   |                     |         |   |                                               |   |     |                             |   |   |                          |   |   |               |       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

----

|                                                                                                                    |   |                                        |     |   |                                        |   |
|-------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------|----------|--------|---------------------------------------------|--------|
|                                                                                                                    |   | Nine      MonthsEndedSeptember      30,2009 |     |   | Nine      MonthsEndedSeptember      30,2008 |   |
| Cash      flows from operating activities:                                                                              |   |                                        |     |   |                                        |   |
| Net      loss                                                                                                           |   | $                                           | (741,964 | )      |                                        | $      | (57,209 | ) |
| Adjustments      to reconcile net loss to net cash used in operating      activities:                                   |   |                                        |     |   |                                        |   |   |   |
| Depreciation      and amortization                                                                                      |   |                                        | 13,835   |   |                                        |   | 12,207 |   |
| Provision      for uncollectible accounts                                                                               |   |                                        | -        |   |                                        |   | 3,425 |   |
| Stock-based      compensation                                                                                           |   |                                        | 196,375  |   |                                        |   | - |   |
| Deferred      taxes                                                                                                     |   |                                        | -        |   |                                        |   | (4,302 | ) |
| Changes      in operating assets and liabilities net of effects of consolidation of      Utilipoint International, Inc: |   |
| Accounts      receivable                                                                                                |   |                                        | 150,795  |   |                                        |   | (81,482 | ) |
| Prepaid      expenses and other current assets                                                                          |   |                                        | 20,074   |   |                                        |   | 86,205 |   |
| Accounts      payable                                                                                                   |   |                                        | 159,794  |   |                                        |   | 2,219 |   |
| Accrued      expenses and other current liabilities                                                                     |   |                                        | 91,623   |   |                                        |   | 54,577 |   |
| Deferred      revenue                                                                                                   |   |                                        | 25,813   |   |                                        |   | (50,599 | ) |
| Management      fees payable                                                                                            |   |                                        | 63,978   |   |                                        |   | 25,000 |   |
| Other                                                                                                                   |   |                                        | 4,310    |   |                                        |   | (11,602 | ) |
| Net      cash used in operating activities                                                                              |   |                                        | (15,367  | )      |                                        |   | (21,561 | ) |
|                                                                                                                    |   |                                        |     |   |                                        |   |   |   |
| Cash      flows from investing activities:                                                                              |   |                                        |     |   |                                        |   |   |   |
| Additions      to property and equipment                                                                                |   |                                        | (1,081   | )      |                                        |   | (2,411 | ) |
| Net      cash acquired from acquisition                                                                                 |   |                                        | 16,482   |   |                                        |   | - |   |
| Net      cash provided by (used in) investing activities                                                                |   |                                        | 15,401   |   |                                        |   | (2,411 | ) |
|                                                                                                                    |   |                                        |     |   |                                        |   |   |   |
| Cash      flows from financing activities:                                                                              |   |                                        |     |   |                                        |   |   |   |
| Net      borrowings (payments) on revolving credit facility                                                             |   |                                        | (163,062 | )      |                                        |   | 164,894 |   |
| Change      in bank overdrafts                                                                                          |   |                                        | -        |   |                                        |   | (113,937 | ) |
| Principal      payments on capital lease obligations                                                                    |   |                                        | (12,639  | )      |                                        |   | (10,362 | ) |
| Principal      payments on notes payable                                                                                |   |                                        | (97,260  | )      |                                        |   | (78,233 | ) |
| Proceeds      from notes payable                                                                                        |   |                                        | 212,046  |   |                                        |   | 150,000 |   |
| Proceeds      from issuance of common stock                                                                             |   |                                        | 25,000   |   |                                        |   | - |   |
| Distribution/dividend      to preferred stockholders                                                                    |   |                                        | -        |   |                                        |   | (68,250 | ) |
| Net      cash provided by (used in) financing activities                                                                |   |                                        | (35,915  | )      |                                        |   | 44,112 |   |
|                                                                                                                    |   |                                        | -        |   |                                        |   |   |   |
| Net      increase (decrease) in cash and cash equivalents                                                               |   |                                        | (35,881  | )      |                                        |   | 20,140 |   |
| Effect      of exchange rate changes on cash and cashequivalents                                                        |   |                                        | 3,670    |   |                                        |   | - |   |
| Cash      and cash equivalents at beginning of period                                                                   |   |                                        | 144,546  |   |                                        |   | - |   |
| Cash      and cash equivalents at end of period                                                                         |   | $                                           | 112,335  |   |                                        | $      | 20,140 |   |
|                                                                                                                    |   |                                        |     |   |                                        |   |   |   |
| Supplemental      disclosure of cash flow information:                                                                  |   |                                        |     |   |                                        |   |   |   |
| Cash      paid during the period for:                                                                                   |   |                                        |     |   |                                        |   |   |   |
| Interest                                                                                                                |   | $                                           | 55,350   |   |                                        | $      | 42,480 |   |
| Taxes                                                                                                                   |   | $                                           | 2,077    |   |                                        | $      | 2,940 |   |
|                                                                                                                    |   |                                        |     |   |                                        |   |   |   |
| Supplemental      disclosure of non-cash financing and investing      activities:                                       |   |                                        |     |   |                                        |   |   |   |
| Property      and equipment acquired under capital leases                                                               |   | $                                           | 1,884    |   |                                        | $      | 13,054 |   |
|                                                                                                                    |   |                                        |     |   |                                        |   |   |   |
|                                                                                                                    |   |                                        |     |   |                                        |   |   |   |

----

| 1)   | The      Company entered into a capital commitment agreement with IP for an amount      of up to $200,000.  IP will be able to make capital requests on      the capital commitment agreement for initial financing.  The      Company received a  60% interest in IP as a result of signing      the capital contribution agreement. As of September 30, 2009, the      Company has provided no capital under the capital commitment      agreement.                                                                                                                                                           |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2)   | The      existing members of IP will provide services to the Company in exchange      for options to purchase an aggregate of 44,747 shares of the common stock      of the Company that are fully-vested on the date of grant and that have a      strike price equal to the fair market value of the Company’s common stock      on the date of grant.  The stock options for the individuals      will be granted pursuant to the equity compensation plan that was adopted      by the Company effective as of May 1, 2009.  All of the stock      options will have a term of five years and a cashless exercise      option. |
| 3)   | The      Company will provide certain management services to IP in exchange for      reasonable compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

----

----

----

----

| Interest      rates                                     |   | Maturity                       |                     | September      30, 2009 |     |    | December      31, 2008 |   |
|---------------------------------------------------------|--------|--------------------------------|--------------------------|-------------------------|----------|---------|------------------------|--------|
|                                                    | 12.00% |                           | 1/1/2010                 |                    | $        | 447,106 |                   |   | $ | 447,106 |   |
|                                                    | 10.00% |                           | 12/31/2013               |                    |     | 62,500  |                   |   |   | 62,500 |   |
|                                                    | 4.00%  |                           | 5/4/2010                 |                    |     | 5,000   |                   |   |   | 5,000 |   |
|                                                    | 4.00%  |                           | 9/23/2009      (1)       |                    |     | 16,000  |                   |   |   | 16,000 |   |
|                                                    | 4.00%  |                           |        6/2/2009 (2) |                    |     | 3,722   |                   |   |   | 9,722 |   |
|                                                    | 10.00% |                           | 1/15/2014                |                    |     | 10,000  |                   |   |   | - |   |
|                                                    | 10.00% |                           | 1/15/2014                |                    |     | 7,500   |                   |   |   | - |   |
|                                                    | 10.00% |                           | 1/15/2014                |                    |     | 7,500   |                   |   |   | - |   |
|                                                    | 5.00%  |                           | 6/30/2012                |                    |     | 108,969 |                   |   |   | - |   |
| Variable,      3% and 4.68% at September 30, 2009 and   |   |                           |                     |                    |     |    |                   |   |   |   |
| December      31, 2008, respectively                    |   |         8/2/2009 (3) |                     |                    | 21,310   |    |                   |   | 35,070 |   |
| Total      long-term debt, including                    |   |                           |                     |                    |     |    |                   |   |   |   |
| current      maturities                                 |   |                           |                     |                    | 689,607  |    |                   |   | 575,398 |   |
| Current      maturities of long-term debt               |   |                           |                     |                    | (493,138 | )       |                   |   | (60,792 | ) |
| Long-term      debt, less current portion               |   |                           |                     |                    | 196,469  |    |                   |   | 514,606 |   |
|                                                    |   |                           |                     |                    |     |    |                   |   |   |   |   |
| Short-term      debt:                                   |   |                           |                     |                    |     |    |                   |   |   |   |
| Revolving      credit facility/note payable Utilipoint  |   |                           |                     |                    | 46,264   |    |                   |   | 216,590 |   |
| Revolving      credit facility Intelligent Project, LLC |   |                           |                     |                    | 7,500    |    |                   |   | - |   |
| Short-term      notes payable                           |   |                           |                     |                    | 577      |    |                   |   | - |   |
| Current      maturities of long-term debt               |   |                           |                     |                    | 493,138  |    |                   |   | 60,792 |   |
| Total      short-term debt                              |   |                           |                     |                    | 547,479  |    |                   |   | 277,382 |   |
| Total      debt                                         |   |                           |                     | $                       | 743,948  |    |                   | $      | 791,988 |   |

| (1)   | The      $16,000 note payable due September 23, 2009 was restructured on August 1,      2009 in connection with the resignation of the Company executive who holds      the note. Per terms of a separation agreement, the former Company      executive agreed to an extension of terms in the amount of two      installments of $2,000 and $14,000 due December 31, 2009 and January 30,      2010, respectively. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | The      same former Company executive also agreed to a payment date of September      30, 2009 for the unpaid portion, $3,722 of the $9,722 note due June 2,      2009 of which $6,000 had been paid on June 2, 2009. Payment of the unpaid      portion of $3,722 was made on October 16,2009. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3)   | In      connection with the employment agreement of one of the management      shareholders, we have agreed to make a principal payment of $5,000 per      month beginning July 31, 2009 in addition to the normal monthly payment      for the variable rate sub-debt note that is due August 2, 2009 until the      note is paid in full. As of September 30, 2009, the outstanding balance      was $21,310. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Year  |   | Amount  |    |
|-------|--------|---------|---------|
| 2010  |   | $  | 493,138 |   |
| 2011  |   |    | -       |   |
| 2012  |   |    | 108,969 |   |
| 2013  |   |    | 62,500  |   |
| 2014  |   |    | 25,000  |   |
| Total |   | $       | 689,607 |   |

----

----

|                                        |   |   |    |   |                |   |   |                      |   |   |                 |   |
|---------------------------------------------|--------|--------|---------|--------|---------------------|--------|--------|---------------------------|--------|--------|----------------------|--------|
|                                        |   |   |    |   | Weighted-Average    |   |   | Weighted-AverageRemaining |   |   | Aggregate            |   |
|                                        |   | Shares |    |   | Exercise      Price |   |   | Contractual      Term     |   |   | Intrinsic      Value |   |
| Outstanding      at January 1, 2009         |   |   | -       |   |                | $      | -      |                      |   |   |                 |   |   |   |
| Granted                                     |   |   | 465,097 |   |                | $      | 2.37   |                      |   |   |                 |   |   |   |
| Exercised                                   |   |   | -       |   |                | $      | -      |                      |   |   |                 |   |   |   |
| Forfeited      or expired                   |   |   | (15,981 | )      |                | $      | 1.56   |                      |   |   |                 |   |   |   |
| Outstanding      at September 30, 2009      |   |   | 449,116 |   |                | $      | 2.40   |                      |   |   | 5.5                  |   |   | $ | 1,113,480 |   |
| Expected      to vest at September 30, 2009 |   |   | 424,741 |   |                | $      | 2.34   |                      |   |   | 5.5                  |   |   | $ | 1,070,199 |   |
| Exercisable      at September 30, 2009      |   |   | 161,616 |   |                | $      | 1.58   |                      |   |   | 5.2                  |   |   | $ | 512,855 |   |

| Expected      dividend yield         |   |   | 0      | %      |
|--------------------------------------|--------|--------|--------|--------|
| Risk-free      rate                  |   |   | 1.59   | %      |
| Expected      stock price volatility |   |   | 103.88 | %      |
| Expected      term (years)           |   |   | 3.1    |   |

----

| Years      Ending December 31,               |   |    |   |   |
|----------------------------------------------|--------|---------|--------|--------|
| 2010                                         |   | $  | 17,838 |   |
| 2011                                         |   |    | 6,143  |   |
| 2012                                         |   |    | 60     |   |
|                                         |   |    | 24,041 |   |
| Less      amount representing interest       |   |    | 2,146  |   |
| Present      value of minimum lease payments |   | $       | 21,895 |   |
| Short-term      portion                      |   | $       | 13,493 |   |
| Long-term      portion                       |   |    | 8,402  |   |
|                                         |   | $       | 21,895 |   |

| Fiscal      year ending December 31, |   | Minimum      Lease Commitments |   |
|--------------------------------------|--------|--------------------------------|--------|
| 2009                                 |   | $                              | 13,687 |   |
| 2010                                 |   |                           | 10,375 |   |
|                                 |   | $                              | 24,062 |   |

----

----

|                                                                                            |   | As      Reported |       |   | Adjustments |    |         | As      Restated |   |
|-------------------------------------------------------------------------------------------------|--------|------------------|------------|--------|-------------|---------|--------------|------------------|--------|
| Consolidated      Balance Sheet and Statement of Stockholders' Deficit September 30,      2009: |   |             |       |   |        |    |         |             |   |
| Preferred      stock                                                                            |   | $                | -          |   |        |    |         |             | $      | - |   |
| Common      stock                                                                               |   |             | 2,736      |   |        |    |         |             |   | 2,736 |   |
| Treasury      stock                                                                             |   |             | (40        | )      |        |    |         |             |   | (40 | ) |
| Additional      paid-in capital                                                                 |   |             | (187,719   | )      |        |    |         |             |   | (187,719 | ) |
| Accumulated      deficit                                                                        |   |             | (1,554,746 | )      |        | $  | 71,041       |             |   |   | (1,483,705 | ) |
| Accumulated      other comprehensive income                                                     |   |             | 8,480      |   |        |    |         |             |   |   | 8,480 |   |
| Total      stockholders' deficit                                                                |   |             | (1,731,289 | )      |        |    |  71,041 |             |   |   | (1,660,248 | ) |
| Non-controlling      interest                                                                   |   |             | -          |   |        |    | (71,041      | )                |   |   | (71,041 | ) |
| Total      deficit                                                                              |   | $                | (1,731,289 | )      |        |    |         |             |   | $ | (1,731,289 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Three      Months Ended September 30, 2009:                                                     |   |             |       |   |        |    |         |             |   |   |   |   |
| Net      loss                                                                                   |   | $                | (513,434   | )      |        |    |         |             |   | $ | (513,434 | ) |
| Less:      Net loss attributable to the non-controllinginterest                                 |   |             | -          |   |        | $  | 69,634       |             |   |   | 69,634 |   |
| Net      loss attributable to Midas Medici Group Holdings,    Inc.                              |   |             | (513,434   | )      |        |    |  69,634 |             |   |   | (443,800 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Preferred      stock dividends and dividend accretion                                           |   |             |       |   |        |    |         |             |   |   |   |   |
| Preferred      stock stated dividends                                                           |   |             | (41,708    | )      |        |    |         |             |   |   | (41,708 | ) |
| Preferred      stock dividend accretion                                                         |   |             | (30,377    | )      |        |    |         |             |   |   | (30,377 | ) |
| Net      loss applicable to common stockholders                                                 |   | $                | (585,519   | )      |        |    | 69,634  |             |   | $ | (515,885 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Net      loss per common share (basic and diluted)                                              |   | $                | (0.37      | )      |        |    |         |             |   | $ | (0.32 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Weighted      average of common shares outstanding (basic and    diluted)                       |   |             | 1,600,037  |   |        |    |         |             |   |   | 1,600,037 |   |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Nine      Months Ended September 30, 2009:                                                      |   |             |       |   |        |    |         |             |   |   |   |   |
| Net      loss                                                                                   |   | $                | (741,964   | )      |        |    |         |             |   | $ | (741,964 | ) |
| Less:      Net loss attributable to the non-controllinginterest                                 |   |             | -          |   |        | $  | 71,041       |             |   |   | 71,041 |   |
| Net      loss attributable to Midas Medici Group Holdings,    Inc.                              |   |             | (741,964   | )      |        |    | 71,041       |             |   |   | (670,923 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Preferred      stock dividends and dividend accretion                                           |   |             |       |   |        |    |         |             |   |   |   |   |
| Preferred      stock stated dividends                                                           |   |             | (109,958   | )      |        |    |         |             |   |   | (109,958 | ) |
| Preferred      stock dividend accretion                                                         |   |             | (203,109   | )      |        |    |         |             |   |   | (203,109 | ) |
| Net      loss applicable to common stockholders                                                 |   | $                | (1,055,031 | )      |        |    | 71,041       |             |   | $ | (983,990 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Net      loss per common share (basic and diluted)                                              |   | $                | (0.69      | )      |        |    |         |             |   | $ | (0.64 | ) |
|                                                                                            |   |             |       |   |        |    |         |             |   |   |   |   |
| Weighted      average of common shares outstanding (basic and    diluted)                       |   |             | 1,531,736  |   |        |    |         |             |   |   | 1,531,736 |   |

----

| •         | Our      ability to attract and retainmanagement, |
|---------------------------|---------------------------------------------------|

| •         | Our      ability to raise capital when needed and on acceptable terms and      conditions; |
|---------------------------|--------------------------------------------------------------------------------------------|

| •         | The      intensity of competition; and |
|---------------------------|----------------------------------------|

| •         | General      economic conditions. |
|---------------------------|-----------------------------------|

----

----

----

----

----

----

| Part II.         | OTHER      INFORMATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item      1.               | Legal      Proceedings                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       | None.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item      1A.              | Risk      Factors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       | Not      applicable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item      2.               | Unregistered      Sales of Equity Securities and Use of Proceeds                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       | The      Company issued 80,000 shares of common stock on July 17, 2009, 30,000      shares of common stock on July 31, 2009 and 52,000 of common stock on      August 14, 2009 to investors for an aggregate purchase price of      $340,200.  On      August 21, 2009, in connection with the acquisition of Utilipoint, we      issued an aggregate of 1,348,516 shares of common stock to the Utilipoint      stockholders in exchange for 42,191 Utilipoint common shares and 172,597      options in exchange for 5,400 Utilipoint options. In addition, Knox      Lawrence International, LLC, KLI IP Holding, Inc. and UTP International      LLC, former shareholders of Utilipoint, acquired an aggregate of 889,444      shares of our common stock and 27,168 options at the closing of      the Merger. Nana Baffour, our CEO and Johnson Kachidza, our President, are      key shareholders of Knox Lawrence International, LLC, KLI IP Holding, Inc.      and UTP International, LLC. In addition, we issued options to purchase      25,000 shares of our common stock to David Steele, President of Utilipoint      and options to purchase 10,000 of our common stock each to Peter Shaw,      Managing Director of The Intelligent Project and Stephen Schweich, our      Director. We      believe that the offer and sale of the securities referenced were exempt      from registration under the Securities Act by virtue of Section 4(2)      of the Securities Act and/or Regulation D promulgated thereunder as      transactions not involving any public offering. All of the purchasers of      unregistered securities for which we relied on Section 4(2) and/or      Regulation D represented that they were accredited investors as      defined under the Securities Act, except for up to 35 non-accredited      investors. The purchasers in each case represented that they intended to      acquire the securities for investment only and not with a view to the      distribution thereof and that they either received adequate information      about the registrant or had access, through employment or other      relationships, to such information; appropriate legends were affixed to      the stock certificates issued in such transactions; and offers and sales      of these securities were made without general solicitation or      advertising. |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item      3.               | Defaults      Upon Senior Securities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       | None.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item 4.          | Submission      of Matters to a Vote of Security Holders                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       | None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item      5.               | Other      Information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                       | None.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item      6.               | Exhibits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

| (a)   | Exhibits |
|-----------------|----------|

| Exhibit      Number |   | Description      of Exhibit                                                                                                                                                                                 |
|---------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                |   |                                                                                                                                                                                                        |
| 31                  |   | Certifications      of Principal Executive Officer and Principal Financial Officer pursuant to      Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities Exchange      Act of 1934, as amended  |
|                |   |                                                                                                                                                                                                        |
| 32                  |   | Certifications      of Principal Executive Officer and Principal Financial Officer pursuant to      18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002  |

----

|                  | Midas      Medici Group Holdings, Inc. |                                                                         |
|-----------------------|----------------------------------------|------------------------------------------------------------------------------|
|                  |                                   |                                                                         |   |
| January      19, 2010 | By:                                    | /s/      Nana Baffour                                                        |   |
|                  |                                   | Nana      Baffour                                                            |   |
|                  |                                   | Chief      Executive Officer (Principal Executive Officer)                   |   |
|                  |                                   |                                                                         |   |
|                  |                                   |                                                                         |   |
|                  |                                   |  /s/ Johnson      Kachidza                                         |   |
|                  |                                   | Johnson      Kachidza                                                        |   |
|                  |                                   | Chief      Financial Officer (Principal Financial and Accounting    Officer) |   |